Retatrutide

10mg · Lyophilized Powder

Retatrutide is an investigational triple-receptor agonist peptide (targets GLP-1, GIP, and glucagon receptors) under development for obesity and type 2 diabetes. Phase 2 trials demonstrated remarkable weight-loss efficacy, with patients losing up to 24% of body weight at 48 weeks on higher doses. The glucagon receptor component drives increased energy expenditure and hepatic fat oxidation, differentiating Retatrutide from dual-agonist compounds. Its modified structure provides a six-day half-life suitable for once-weekly research protocols.

All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.